417 related articles for article (PubMed ID: 19388581)
1. [Snake venom disintegrins: classification and therapeutic potential].
Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N
Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581
[TBL] [Abstract][Full Text] [Related]
2. Colombistatin: a disintegrin isolated from the venom of the South American snake (Bothrops colombiensis) that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion.
Sánchez EE; Rodríguez-Acosta A; Palomar R; Lucena SE; Bashir S; Soto JG; Pérez JC
Arch Toxicol; 2009 Mar; 83(3):271-9. PubMed ID: 18830584
[TBL] [Abstract][Full Text] [Related]
3. Leberagin-C, A disintegrin-like/cysteine-rich protein from Macrovipera lebetina transmediterranea venom, inhibits alphavbeta3 integrin-mediated cell adhesion.
Limam I; Bazaa A; Srairi-Abid N; Taboubi S; Jebali J; Zouari-Kessentini R; Kallech-Ziri O; Mejdoub H; Hammami A; El Ayeb M; Luis J; Marrakchi N
Matrix Biol; 2010 Mar; 29(2):117-26. PubMed ID: 19808093
[TBL] [Abstract][Full Text] [Related]
4. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
Schönthal AH; Swenson SD; Chen TC; Markland FS
Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
[TBL] [Abstract][Full Text] [Related]
5. Structure-function correlations of snake venom disintegrins.
Calvete JJ
Curr Pharm Des; 2005; 11(7):829-35. PubMed ID: 15777237
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of two disintegrins inhibiting ADP-induced human platelet aggregation from the venom of Crotalus scutulatus scutulatus (Mohave Rattlesnake).
Sánchez EE; Galán JA; Russell WK; Soto JG; Russell DH; Pérez JC
Toxicol Appl Pharmacol; 2006 Apr; 212(1):59-68. PubMed ID: 16084550
[TBL] [Abstract][Full Text] [Related]
7. Snake venom disintegrins: evolution of structure and function.
Calvete JJ; Marcinkiewicz C; Monleón D; Esteve V; Celda B; Juárez P; Sanz L
Toxicon; 2005 Jun; 45(8):1063-74. PubMed ID: 15922775
[TBL] [Abstract][Full Text] [Related]
8. Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering.
Calvete JJ; Moreno-Murciano MP; Theakston RD; Kisiel DG; Marcinkiewicz C
Biochem J; 2003 Jun; 372(Pt 3):725-34. PubMed ID: 12667142
[TBL] [Abstract][Full Text] [Related]
9. Functional characteristic of snake venom disintegrins: potential therapeutic implication.
Marcinkiewicz C
Curr Pharm Des; 2005; 11(7):815-27. PubMed ID: 15777236
[TBL] [Abstract][Full Text] [Related]
10. Evolution of snake venom disintegrins by positive Darwinian selection.
Juárez P; Comas I; González-Candelas F; Calvete JJ
Mol Biol Evol; 2008 Nov; 25(11):2391-407. PubMed ID: 18701431
[TBL] [Abstract][Full Text] [Related]
11. From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.
Kuo YJ; Chung CH; Huang TF
Toxins (Basel); 2019 Jun; 11(7):. PubMed ID: 31247995
[TBL] [Abstract][Full Text] [Related]
12. [The anti-platelet aggregation drugs: new approaches based on snake venom polypeptides].
Marrakchi N; Guermazi S; El Ayeb M
Arch Inst Pasteur Tunis; 1997; 74(1-2):9-15. PubMed ID: 15945171
[No Abstract] [Full Text] [Related]
13. [Snake venoms C-type lectins and their receptors on platelets and cancerous cells].
Sarray S; Luis J; El Ayeb M; Marrakchi N
Arch Inst Pasteur Tunis; 2008; 85(1-4):69-80. PubMed ID: 19469418
[TBL] [Abstract][Full Text] [Related]
14. [Potential use of snake venom components in cancer treatment].
Vivas D; Inga R; Yarlequé A
Rev Peru Med Exp Salud Publica; 2012; 29(3):396-401. PubMed ID: 23085804
[TBL] [Abstract][Full Text] [Related]
15. How snake venom disintegrins affect platelet aggregation and cancer proliferation.
Kolvekar N; Bhattacharya N; Sarkar A; Chakrabarty D
Toxicon; 2023 Jan; 221():106982. PubMed ID: 36435228
[TBL] [Abstract][Full Text] [Related]
16. "Insularin, a disintegrin from Bothrops insularis venom: inhibition of platelet aggregation and endothelial cell adhesion by the native and recombinant GST-insularin proteins".
Della-Casa MS; Junqueira-de-Azevedo I; Butera D; Clissa PB; Lopes DS; Serrano SM; Pimenta DC; Magalhães GS; Ho PL; Moura-da-Silva AM
Toxicon; 2011 Jan; 57(1):125-33. PubMed ID: 21073888
[TBL] [Abstract][Full Text] [Related]
17. Disintegrins.
McLane MA; Sanchez EE; Wong A; Paquette-Straub C; Perez JC
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):327-55. PubMed ID: 15578957
[TBL] [Abstract][Full Text] [Related]
18. The continuing saga of snake venom disintegrins.
Calvete JJ
Toxicon; 2013 Feb; 62():40-9. PubMed ID: 23010163
[TBL] [Abstract][Full Text] [Related]
19. Anti-platelet effect of cumanastatin 1, a disintegrin isolated from venom of South American Crotalus rattlesnake.
Da Silva M; Lucena S; Aguilar I; Rodríguez-Acosta A; Salazar AM; Sánchez EE; Girón ME; Carvajal Z; Arocha-Piñango CL; Guerrero B
Thromb Res; 2009 Mar; 123(5):731-9. PubMed ID: 18835011
[TBL] [Abstract][Full Text] [Related]
20. The disintegrin-like domain of the snake venom metalloprotease alternagin inhibits alpha2beta1 integrin-mediated cell adhesion.
Souza DH; Iemma MR; Ferreira LL; Faria JP; Oliva ML; Zingali RB; Niewiarowski S; Selistre-de-Araujo HS
Arch Biochem Biophys; 2000 Dec; 384(2):341-50. PubMed ID: 11368322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
